2016年9月
Partial loss of CALM function reduces A beta 42 production and amyloid deposition in vivo
HUMAN MOLECULAR GENETICS
- ,
- ,
- ,
- ,
- ,
- 巻
- 25
- 号
- 18
- 開始ページ
- 3988
- 終了ページ
- 3997
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1093/hmg/ddw239
- 出版者・発行元
- OXFORD UNIV PRESS
Aberrant production, clearance and deposition of amyloid-beta protein (A beta) in the human brain have been implicated in the aetiology of Alzheimer disease (AD). gamma-Secretase is the enzyme responsible for generating various Ab species, such as A beta 40 and toxic A beta 42. Recently, genome-wide association studies in late-onset AD patients have identified the endocytosis-related phosphatidylinositol-binding clathrin assembly protein (PICALM) gene as a genetic risk factor for AD. We previously found that the loss of expression of CALM protein encoded by PICALM affects the ratio of production of A beta 42, through the regulation of the clathrin-mediated endocytosis of c-secretase. Here, we show that the binding capacity of the assembly protein 180 N-terminal homology (ANTH) domain of CALM to phosphatidylinositol-4,5-biphosphate, as well as to nicastrin, is critical to the modulation of the internalization of gamma-secretase and to the A beta 42 production ratio. Moreover, reduction of CALM decreases Ab deposition as well as brain levels of insoluble A beta 42 in vivo. These results suggest that CALM expression modifies AD risk by regulating Ab pathology.
- リンク情報
- ID情報
-
- DOI : 10.1093/hmg/ddw239
- ISSN : 0964-6906
- eISSN : 1460-2083
- Web of Science ID : WOS:000395806000008